Piper Sandler resumed coverage on Cutera with a new price target
$CUTR
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Health Care
Piper Sandler resumed coverage of Cutera with a rating of Underweight and set a new price target of $14.00